Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility

Florida-based CDMO Formulated Solutions announced that it has acquired a 455,000 sq ft production facility in Cleveland, TN, USA that includes two buildings fitted with pharmaceutical production and packaging lines for a variety of dose forms such as liquids, bag-on-valve aerosols, and nasal sprays. The Tennessee facility was most recently owned by German skincare company Beiersdorf, which had acquired the plant from Bayer Healthcare in 2019. Formulated Solutions completed an addition of nasal spray manufacturing capabilities to its Florida plant in January 2022.

The company said, “Upon completion, the acquisition will strengthen Formulated Solutions’ capabilities in topicals, metered dose nasal sprays, and pressurized package manufacturing and allow the company to quickly bring additional production capacity online in service of current commercial demand while also paving the way for fulfillment of their future innovation pipeline.”

Formulated Solutions Chief Operating Officer John Maddox commented, “With an average year over year growth of well over 50% annually, Formulated Solutions is thrilled to add the aerosol, bag-on-valve, and liquid-fill capabilities of this 455,000 square foot site to our manufacturing assets. Our customers, consumers, physicians, and patients rely on us each and every day to supply high quality, cost-effective solutions for consumer self-care and physician advised treatments. This acquisition will help us further fulfill that commitment to all our marketing partners as our business continues to grow and evolve.”

Read the Formulated Solutions press release.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan